-
Autor
Aiello, Valeria 1 Al-Rabadi, Laith 1 Ars, Elisabet 1 Ashton, Emma 1 Becherucci, Francesca 1 Belge, Hendica 1 Bierzynska, Agnieszka 1 Byers, Peter 1 Cerkauskaite, Agne 1 Cerkauskiene, Rimante 1 Claes, Kathleen 1 Corveleyn, Anniek 1 Deltas, Constantinos 1 Errichiello, Carmela 1 Flinter, Frances 1 Gangemi, Concetta 1 Gear, Susie 1 Gregory, Martin 1 Gupta, Asheeta 1 Hertz, Jens Michael 1
-
Pracoviště
Alport UK United Kingdom 1 Birmingham Children's Hospital Birmingham Un... 1 Bristol Genetics Laboratory Pathology Scienc... 1 Bristol Renal Unit Bristol Medical School Un... 1 Center for Human Genetics University Hospita... 1 Center of Excellence in Biobanking and Biome... 1 Centre for Nephrology and Metabolic Disorder... 1 Centre for Rare Diseases and Clinical Geneti... 1 Clinic of Pediatrics Institute of Clinical M... 1 Departement de Biologie Moleculaire Institut... 1 Department of Biology School of Medicine Uni... 1 Department of Biomedical Sciences University... 1 Department of Clinical Genetics Guy's and St... 1 Department of Clinical Genetics Maastricht U... 1 Department of Clinical Genetics Odense Unive... 1 Department of Experimental Diagnostic and Sp... 1 Department of Genetics University Medical Ce... 1 Department of Medical Biotechnology Medical ... 1 Department of Medical Genetics University Ho... 1 Department of Medicine The University of Mel... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
NLK
Free Medical Journals
od 2006 do Před 1 rokem
PubMed Central
od 2008 do Před 1 rokem
Europe PubMed Central
od 2008 do Před 1 rokem
Open Access Digital Library
od 2006-01-01
PubMed
34930753
DOI
10.2215/cjn.04230321
Knihovny.cz E-zdroje
Genetic testing for pathogenic COL4A3-5 variants is usually undertaken to investigate the cause of persistent hematuria, especially with a family history of hematuria or kidney function impairment. Alport syndrome experts now advocate genetic testing for persistent hematuria, even when a heterozygous pathogenic COL4A3 or COL4A4 is suspected, and cascade testing of their first-degree family members because of their risk of impaired kidney function. The experts recommend too that COL4A3 or COL4A4 heterozygotes do not act as kidney donors. Testing for variants in the COL4A3-COL4A5 genes should also be performed for persistent proteinuria and steroid-resistant nephrotic syndrome due to suspected inherited FSGS and for familial IgA glomerulonephritis and kidney failure of unknown cause.
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.